2017 ORADE Grants! Now Accepting Applications!More
ORA 16th Annual General MeetingMore
We look forward to seeing you at the ORA 16th Annual General Meeting May 26-28, 2017!
ORA Members Honoured at the 2016 ACR Annual Meeting in Washington
Congratulations to Dr. Carter Thorne, Dr. Claire Bombardier and Dr. Daphne Gladman
Retreatment with Rituximab (Rituxan) through EAP.
EAP will now approve Rituximab renewals in advance of loss of effect/flare.
Good News on EAP Approvals!
The ORA EAP Committee recently met with the governement to discuss lengthy EAP approval timelines. Immediate action steps have been taken. Read more
- View All News
Diamond: Pfizer Canada Inc., Amgen Canada Inc., Celgene Inc., AbbVie Canada, UCB Canada Inc., Novartis Canada
Platinum: Janssen Inc., Eli Lilly, Bristol-Myers Squibb Canada
Gold: Hospira, Roche Canada,
Silver: Medexus Inc., Merck, Sanofi
Specialty Pharmacy: Sobi, Bedrocan